chlorpromazine has been researched along with flufenamic acid in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (50.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
Kazui, S; Kobayashi, K; Tanaka, K | 1 |
Chinea, G; Oronsky, AL; Perper, RJ; Sanda, M | 1 |
Malone, MH; Trottier, RW | 1 |
Ignarro, LJ | 1 |
Molinas, F; von Kaulla, KN | 1 |
Irie, T; Otagiri, M; Sunada, M; Tsubaki, K; Uekama, K | 1 |
Iida, T; Kado, Y; Morimoto, Y; Shiota, M; Takeuchi, Y; Yutani, Y | 1 |
1 review(s) available for chlorpromazine and flufenamic acid
Article | Year |
---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |
13 other study(ies) available for chlorpromazine and flufenamic acid
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Temperature-dependent reaction of flufenamic acid with rat erythrocyte membrane.
Topics: Anesthetics, Local; Animals; Anti-Inflammatory Agents; Cell Membrane; Chlorpromazine; Dose-Response Relationship, Drug; Erythrocytes; Flufenamic Acid; Hemolysis; Histamine H1 Antagonists; In Vitro Techniques; Rats; Spectrometry, Fluorescence; Temperature; Tranquilizing Agents | 1973 |
Leukocyte chemotaxis in vivo. II. Analysis of the selective inhibition of neutrophil or mononuclear cell accumulation.
Topics: Animals; Bucladesine; Carrageenan; Chemotaxis; Chloroquine; Chlorpromazine; Chromium Radioisotopes; Clonidine; Colchicine; Cyclophosphamide; Female; Flufenamic Acid; Indomethacin; Inflammation; Leukocyte Transfusion; Leukocytes; Methylprednisolone; Monocytes; Neutrophils; Phenylbutazone; Rats; Transplantation, Homologous; Venoms; Vinblastine | 1974 |
Evaluation of cryogenine on rat paw thermal oedema and rat isolated uterus.
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Benzocaine; Bradykinin; Burns; Chlorpromazine; Dose-Response Relationship, Drug; Edema; Female; Flufenamic Acid; Forelimb; In Vitro Techniques; Indomethacin; Male; Morphine; Phenylbutazone; Plant Extracts; Quinolizines; Rats; Reserpine; Tetrabenazine; Time Factors; Uterus | 1973 |
Lysosome membrane stabilization in vivo: effects of steroidal and nonsteroidal anti-inflammatory drugs on the integrity of rat liver lysosomes.
Topics: Adrenal Glands; Adrenalectomy; Animals; Anti-Inflammatory Agents; Aspirin; Chlorpheniramine; Chlorpromazine; Cyclophosphamide; Dextropropoxyphene; Flufenamic Acid; Glucosidases; Hydrocortisone; In Vitro Techniques; Indomethacin; Kinetics; Liver; Lysosomes; Mefenamic Acid; Membranes; Osmotic Fragility; Oxyphenbutazone; Paramethasone; Phenylbutazone; Rats; Steroids; Vitamin A | 1972 |
On the effect on human thrombocytes of synthetic organic fibrinolytic compounds.
Topics: Adenine Nucleotides; Benzoates; Blood Platelets; Cell Membrane; Chlorpromazine; Epinephrine; Fibrinolytic Agents; Flufenamic Acid; Fluorescence; Guanidines; Humans; Nucleosides; ortho-Aminobenzoates; Ouabain; Prednisolone; Salicylates; Serum Albumin; Succinates; Thrombin | 1969 |
Protective effects of cyclodextrins on drug-induced hemolysis in vitro.
Topics: Chlorpromazine; Cyclodextrins; Dextrins; Erythrocytes; Flufenamic Acid; Hemolysis; Humans; In Vitro Techniques; Starch | 1981 |
Protective effects of neutral amino acids against amphipathic drug-induced hemolysis.
Topics: Amino Acids; Animals; Carbohydrates; Chlorpromazine; Erythrocytes; Flufenamic Acid; Hemolysis; In Vitro Techniques; Kinetics; Molecular Weight; Osmolar Concentration; Phospholipids; Rabbits | 1995 |